Manufacturers Life Insurance Company, The Beam Therapeutics Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 145,851 shares of BEAM stock, worth $4.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
145,851
Previous 137,089 6.39%
Holding current value
$4.23 Million
Previous $3.21 Million 11.27%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$22.57 - $33.14 $197,758 - $290,372
8,762 Added 6.39%
145,851 $3.57 Million
Q2 2024

Aug 14, 2024
BUY
$21.22 - $32.66 $684,960 - $1.05 Million
32,279 Added 30.8%
137,089 $3.21 Million
Q1 2024

May 14, 2024
BUY
$23.46 - $45.07 $1.65 Million - $3.16 Million
70,186 Added 202.71%
104,810 $3.46 Million
Q4 2023

Feb 13, 2024
BUY
$17.69 - $30.76 $19,618 - $34,112
1,109 Added 3.31%
34,624 $942,000
Q3 2023

Nov 15, 2023
BUY
$23.01 - $32.46 $140,545 - $198,265
6,108 Added 22.29%
33,515 $806,000
Q2 2023

Aug 11, 2023
BUY
$29.32 - $35.99 $53,567 - $65,753
1,827 Added 7.14%
27,407 $875,000
Q1 2023

May 15, 2023
SELL
$30.15 - $48.79 $5,125 - $8,294
-170 Reduced 0.66%
25,410 $778,000
Q4 2022

Aug 11, 2023
BUY
$36.73 - $51.6 $12,598 - $17,698
343 Added 1.36%
25,580 $1 Million
Q4 2022

Feb 13, 2023
BUY
$36.73 - $51.6 $12,598 - $17,698
343 Added 1.36%
25,580 $1 Million
Q3 2022

Aug 11, 2023
SELL
$39.79 - $70.31 $18,621 - $32,905
-468 Reduced 1.82%
25,237 $1.2 Million
Q3 2022

Nov 03, 2022
SELL
$39.79 - $70.31 $18,621 - $32,905
-468 Reduced 1.82%
25,237 $1.2 Million
Q2 2022

Aug 11, 2023
BUY
$29.86 - $62.36 $133,504 - $278,811
4,471 Added 21.06%
25,705 $995,000
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $133,504 - $278,811
4,471 Added 21.06%
25,705 $995,000
Q1 2022

Aug 11, 2023
SELL
$53.73 - $82.16 $224,376 - $343,100
-4,176 Reduced 16.43%
21,234 $1.22 Million
Q1 2022

May 20, 2022
SELL
$53.73 - $82.16 $242,644 - $371,034
-4,516 Reduced 17.54%
21,234 $1.22 Million
Q4 2021

Feb 16, 2022
BUY
$68.02 - $99.06 $30,813 - $44,874
453 Added 1.79%
25,750 $2.05 Million
Q3 2021

Nov 12, 2021
SELL
$84.37 - $133.6 $83,779 - $132,664
-993 Reduced 3.78%
25,297 $2.2 Million
Q2 2021

Aug 12, 2021
BUY
$64.12 - $128.71 $260,968 - $523,849
4,070 Added 18.32%
26,290 $3.38 Million
Q1 2021

May 03, 2021
SELL
$71.28 - $120.75 $99,007 - $167,721
-1,389 Reduced 5.88%
22,220 $1.78 Million
Q4 2020

Feb 12, 2021
BUY
$22.24 - $95.63 $84,801 - $364,637
3,813 Added 19.26%
23,609 $1.93 Million
Q3 2020

Nov 09, 2020
BUY
$19.0 - $30.57 $376,124 - $605,163
19,796 New
19,796 $487,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.04B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email